why choose us

First received: August 15, 2022

Clinical Trial: Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: NAFLD

Study Type: INTERVENTIONAL


Official Title: Dasatinib and Quercetin, a Combination of Senolytics to Treat Fibrotic Non-alcoholic Fatty Liver Disease - the TRUTH Study

Brief Summary: To examine the effect of dasatinib plus quercetin on liver fibrosis in individuals with biopsy proven NAFLD with fibrosis by performing a double-blind randomized controlled proof-of-principle study

Read more